HR 6255 United States House · 119th Congress

Affordable Insulin Now Act

HR 6255, the Affordable Insulin Now Act, requires health insurance plans (including employer-sponsored and individual plans) to cover specific insulin products starting in 2026. It caps out-of-pocket costs for these insulin products at $35 per 30-day supply or 25% of the negotiated price, whichever is lower, with no deductibles applied. The bill defines "selected insulin products" to include at least one of each dosage form (like vials or pumps) and type (such as rapid-acting or long-acting) available from the plan. This directly affects people with diabetes who rely on insulin, ensuring more predictable and affordable access to essential medications under their health coverage.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Nov 2025

Committee Review

Floor Vote

President

Introduced Nov 21, 2025 Last action Nov 21, 2025

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Nov 21, 2025

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Nov 21, 2025

Introduced

Introduced in House

lower

1 primary · 9 co-sponsors